Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation

British Journal of Surgery

Volumn 99, Issue 4, 2012, Pages 567-575

  Govaert, K M ^a   Nijkamp, M W ^a   Emmink, B L ^a   Steller, E J A ^a   Minchinton, A I ^b   Kranenburg, O ^a   Borel Rinkes, I H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PRODRUG; TIRAPAZAMINE; TRIAZINE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CATHETER ABLATION; CELL HYPOXIA; COLORECTAL TUMOR; DRUG EFFECT; FLOW CYTOMETRY; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MOUSE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CATHETER ABLATION; CELL HYPOXIA; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PRODRUGS; TRIAZINES; TUMOR CELLS, CULTURED;

EID: 84858077807     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8668     Document Type: Article

References (31)

1. Leonard GD, Brenner B, Kemeny NE,. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23: 2038-2048. (Pubitemid 46211384)
2. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM,. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254-259. (Pubitemid 44305540)
3. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
4. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M,. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94: 982-999.
5. Scheele J, Stang R, Altendorf-Hofmann A, Paul M,. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
6. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al., Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
7. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L,. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171. (Pubitemid 41033431)
8. Siperstein AE, Berber E, Ballem N, Parikh RT,. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007; 246: 559-565. (Pubitemid 47480598)
9. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD III, Dorfman GS, et al., American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: 493-508.
10. Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y,. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 2008; 25: 445-460.
11. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I,. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90: 1240-1243. (Pubitemid 37330428)
12. Ruers TJ, Punt CJ, Coevorden F, Borel Rinkes IHM, Ledermann JA, Poston GJ, et al., Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). J Clin Oncol 2010; 28: 15s.
13. Hompes D, Prevoo W, Ruers T,. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011; 11: 23-30.
14. Veenendaal LM, van Hillegersberg R, Smakman N, van der Bilt JD, van Diest PJ, Kranenburg O, et al., Synergistic effect of interstitial laser coagulation and doxorubicin in a murine tumor recurrence model of solitary colorectal liver metastasis. Ann Surg Oncol 2006; 13: 168-175. (Pubitemid 43157410)
15. Nijkamp MW, van der Bilt JD, de Bruijn MT, Molenaar IQ, Voest EE, van Diest PJ, et al., Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg 2009; 249: 814-823.
16. Zeman EM, Brown JM, Lemmon MJ, Hirst VK, Lee WW,. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys 1986; 12: 1239-1242. (Pubitemid 16055893)
17. Brown JM,. The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999; 59: 5863-5870. (Pubitemid 30004940)
18. Wang J, Biedermann KA, Brown JM,. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation. Cancer Res 1992; 52: 4473-4477.
19. Rischin D, Narayan K, Oza AM, Mileshkin L, Bernshaw D, Choi J, et al., Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer. Int J Gynecol Cancer 2010; 20: 827-833.
20. Le QT, Moon J, Redman M, Williamson SK, Lara PN Jr, Goldberg Z, et al., Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. J Clin Oncol 2009; 27: 3014-3019.
21. Rischin D, Peters L, Fisher R, Macann A, Denham J, Poulsen M, et al., Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 2005; 23: 79-87. (Pubitemid 41702625)
22. von Pawel J, von Roemeling R, Gatzemeier U, Boyer M, Elisson LO, Clark P, et al., Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: a report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors. J Clin Oncol 2000; 18: 1351-1359. (Pubitemid 30159856)
23. Lartigau E, Guichard M,. The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours. Br J Cancer 1996; 73: 1480-1485. (Pubitemid 26235370)
24. Huxham LA, Kyle AH, Baker JH, McNicol KL, Minchinton AI,. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts. Radiother Oncol 2006; 78: 138-145. (Pubitemid 43344172)
25. Nijkamp MW, Hoogwater FJ, Steller EJ, Westendorp BF, van der Meulen TA, Leenders MW, et al., CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. J Hepatol 2010; 53: 1069-1077.
26. Lee AE, Wilson WR,. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice. Toxicol Appl Pharmacol 2000; 163: 50-59. (Pubitemid 30111976)
27. Nanko M, Shimada H, Yamaoka H, Tanaka K, Masui H, Matsuo K, et al., Micrometastatic colorectal cancer lesions in the liver. Surg Today 1998; 28: 707-713. (Pubitemid 28341294)
28. Ahmad A, Chen SL, Kavanagh MA, Allegra DP, Bilchik AJ,. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg 2006; 72: 875-879. (Pubitemid 351837622)
29. Cohen EE, Rosine D, Haraf DJ, Loh E, Shen L, Lusinchi A, et al., Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 67: 678-684. (Pubitemid 46215895)
30. Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Nagatani Y, Takahashi M, et al., Enhanced antitumor effect of tirapazamine delivered intraperitoneally to VX2 liver tumor-bearing rabbits subjected to transarterial hepatic embolization. Cardiovasc Intervent Radiol 2011; 34: 1272-1277.
31. Weinberg BD, Blanco E, Lempka SF, Anderson JM, Exner AA, Gao J,. Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment. J Biomed Mater Res A 2007; 81: 205-213. (Pubitemid 46435468)